Mark Tremelling

24.6k total citations
20 papers, 380 citations indexed

About

Mark Tremelling is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, Mark Tremelling has authored 20 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Surgery and 7 papers in Immunology. Recurrent topics in Mark Tremelling's work include Inflammatory Bowel Disease (14 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Microscopic Colitis (4 papers). Mark Tremelling is often cited by papers focused on Inflammatory Bowel Disease (14 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Microscopic Colitis (4 papers). Mark Tremelling collaborates with scholars based in United Kingdom, Australia and United States. Mark Tremelling's co-authors include Miles Parkes, Francesca Bredin, Dunecan Massey, Hu Zhang, Carlo Berzuini, Sheila Bingham, Sarah Waller, Simon Greenfield, Claire Dawson and James Lee and has published in prestigious journals such as Nature Communications, Gastroenterology and Gut.

In The Last Decade

Mark Tremelling

18 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Tremelling United Kingdom 11 182 180 144 89 79 20 380
Keren M. Rabinowitz Israel 10 188 1.0× 102 0.6× 165 1.1× 65 0.7× 113 1.4× 22 401
Laurian Tonenchi Germany 6 139 0.8× 220 1.2× 94 0.7× 84 0.9× 82 1.0× 6 351
Thomas Krummenerl Germany 4 265 1.5× 128 0.7× 150 1.0× 71 0.8× 129 1.6× 4 425
Renata Curciarello Argentina 14 162 0.9× 155 0.9× 125 0.9× 106 1.2× 73 0.9× 25 474
Derek Patel United States 9 105 0.6× 74 0.4× 135 0.9× 49 0.6× 114 1.4× 14 383
Pamela Mundt Germany 6 247 1.4× 366 2.0× 96 0.7× 59 0.7× 110 1.4× 7 578
AnnKatrin Petersen United States 5 331 1.8× 105 0.6× 109 0.8× 90 1.0× 200 2.5× 12 483
Heather Evans‐Marin United States 8 90 0.5× 229 1.3× 232 1.6× 41 0.5× 52 0.7× 11 509
Nitish Rana United States 7 73 0.4× 228 1.3× 351 2.4× 99 1.1× 37 0.5× 10 507
Aaron Fleming United Kingdom 6 82 0.5× 190 1.1× 92 0.6× 60 0.7× 64 0.8× 6 339

Countries citing papers authored by Mark Tremelling

Since Specialization
Citations

This map shows the geographic impact of Mark Tremelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tremelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tremelling more than expected).

Fields of papers citing papers by Mark Tremelling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tremelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tremelling. The network helps show where Mark Tremelling may publish in the future.

Co-authorship network of co-authors of Mark Tremelling

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tremelling. A scholar is included among the top collaborators of Mark Tremelling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tremelling. Mark Tremelling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Módos, Dezső, Padhmanand Sudhakar, Matthew Madgwick, et al.. (2022). A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis. Nature Communications. 13(1). 2299–2299. 16 indexed citations
2.
Tremelling, Mark, Louise Hamilton, Matthew Kim, et al.. (2022). Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: secondary care cross-sectional study. Lara D. Veeken. 62(4). 1511–1518. 6 indexed citations
3.
Nelson, Andrew, Christopher J. Stewart, Nicholas A. Kennedy, et al.. (2020). The Impact ofNOD2Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation. Journal of Crohn s and Colitis. 15(5). 800–812. 32 indexed citations
4.
Tremelling, Mark, et al.. (2020). SAT0380 ENHANCING RHEUMATOLOGY REFERRALS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS WITH SUSPECTED AXIAL SPONDYLOARTHRITIS. Annals of the Rheumatic Diseases. 79. 1138–1138. 1 indexed citations
5.
6.
Kennedy, Nicholas A., Christopher A Lamb, Susan H. Berry, et al.. (2018). The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease. Inflammatory Bowel Diseases. 24(3). 583–592. 38 indexed citations
7.
Kennedy, Nicholas A., Christopher A Lamb, Steff Lewis, et al.. (2014). PWE-082 The Impact Of Nod2 Variants On Gut Microbiota In Crohn’s Disease And Healthy Controls. Gut. 63(Suppl 1). A159.2–A160. 3 indexed citations
8.
9.
Hewitt, Rachel E., Laetitia Pele, Mark Tremelling, et al.. (2012). Immuno-inhibitory PD-L1 can be induced by a Peptidoglycan/NOD2 mediated pathway in primary monocytic cells and is deficient in Crohn's patients with homozygous NOD2 mutations.. Clinical Immunology. 143(2). 162–169. 27 indexed citations
10.
Lewis, Michael, Wing Leung, Nigel J. Belshaw, et al.. (2011). Compromised Tissue Renewal in the Ageing Human Colonic Epithelium. Gastroenterology. 140(5). S–321. 2 indexed citations
11.
Lewis, Gregory J., Dunecan Massey, Hu Zhang, et al.. (2010). Genetic association between NLRP3 variants and Crohnʼs disease does not replicate in a large UK panel. Inflammatory Bowel Diseases. 17(6). 1387–1391. 53 indexed citations
12.
Tremelling, Mark, Carlo Berzuini, Dunecan Massey, et al.. (2008). Contribution of TNFSF15 gene variants to Crohnʼs disease susceptibility confirmed in UK population. Inflammatory Bowel Diseases. 14(6). 733–737. 59 indexed citations
13.
Zhang, Hu, Dunecan Massey, Mark Tremelling, & Miles Parkes. (2008). Genetics of inflammatory bowel disease: clues to pathogenesis. British Medical Bulletin. 87(1). 17–30. 44 indexed citations
14.
Baburajan, Bijay, Natalie J. Prescott, K Herrlinger, et al.. (2007). HLA-G 14BP insertion-deletion polymorphism influences response to methotrexate in inflammatory bowel disease.. Gut. 56. 1 indexed citations
15.
Baburajan, Bijay, M Arenas, Natalie J. Prescott, et al.. (2007). The pharmacogenetics of folate and purine metabolic pathways in methotrexate therapy of inflammatory bowel disease.. Gut. 56. 1 indexed citations
16.
Johnson, C. Mark, James A. Traherne, Scott Jamieson, et al.. (2007). Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn’s disease. Tissue Antigens. 69(3). 236–241. 20 indexed citations
17.
Tremelling, Mark & Miles Parkes. (2007). Genome-wide association scans identify multiple confirmed susceptibility loci for Crohnʼs disease: Lessons for study design. Inflammatory Bowel Diseases. 13(12). 1554–1560. 12 indexed citations
18.
Tremelling, Mark, Charlie W. Lees, John Mansfield, et al.. (2007). Reply. Gastroenterology. 133(3). 1051–1052. 1 indexed citations
19.
Tremelling, Mark, Sarah Waller, Francesca Bredin, Simon Greenfield, & Miles Parkes. (2006). Genetic variants in TNF-α but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflammatory Bowel Diseases. 12(3). 178–184. 39 indexed citations
20.
Tremelling, Mark, et al.. (2006). Complex insertion/deletion polymorphism in NOD1 (CARD4) is not associated with inflammatory bowel disease susceptibility in East Anglia panel. Inflammatory Bowel Diseases. 12(10). 967–971. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keren M. Rabinowitz Breakdown of academic impact, for papers by Laurian Tonenchi Breakdown of academic impact, for papers by Thomas Krummenerl Breakdown of academic impact, for papers by Renata Curciarello Breakdown of academic impact, for papers by Derek Patel Breakdown of academic impact, for papers by Pamela Mundt Breakdown of academic impact, for papers by AnnKatrin Petersen Breakdown of academic impact, for papers by Heather Evans‐Marin Breakdown of academic impact, for papers by Nitish Rana Breakdown of academic impact, for papers by Aaron Fleming
Rankless by CCL
2026